United States Pediatric Vaccines Market 2020 – 2027

Report ID: 49763 | Published Date: Sep 2024 | No. of Page: 120 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1. Executive Summary

2. United States Pediatric Vaccines Market Analysis, 2015 – 2019 and Forecast, 2020 – 2027

3. United States Pediatric Vaccines Market Share and Y–o–Y Growth (%)

4. Key Market Drivers and Inhibitors of the United States Pediatric Vaccines Market
4.1 Market Drivers
4.2 Market Inhibitors

5. United States Pediatric Vaccines Market – By Disease Indication (2015 – 2027) 
5.1 Polio
5.1.1 Doses Administered (Volume) 
5.1.2 Number of Children Being Vaccinated (Volume) 
5.1.3 Market Size and Forecast (Value) 
5.2 Hepatitis B
5.2.1 Doses Administered (Volume) 
5.2.2 Number of Children Being Vaccinated (Volume) 
5.2.3 Market Size and Forecast (Value) 
5.3 Hepatitis A
5.3.1 Doses Administered (Volume) 
5.3.2 Number of Children Being Vaccinated (Volume) 
5.3.3 Market Size and Forecast (Value) 
5.4 Diphtheria, Tetanus & Pertussis (DTaP) 
5.4.1 Doses Administered (Volume) 
5.4.2 Number of Children Being Vaccinated (Volume) 
5.4.3 Market Size and Forecast (Value) 
5.5 Haemophilus Influenzae Type B (HIB) 
5.5.1 Doses Administered (Volume) 
5.5.2 Number of Children Being Vaccinated (Volume) 
5.5.3 Market Size and Forecast (Value) 
5.6 Pneumococcal
5.6.1 Doses Administered (Volume) 
5.6.2 Number of Children Being Vaccinated (Volume) 
5.6.3 Market Size and Forecast (Value) 
5.7 Measles, Mumps & Rubella (MMR) 
5.7.1 Doses Administered (Volume) 
5.7.2 Number of Children Being Vaccinated (Volume) 
5.7.3 Market Size and Forecast (Value) 
5.8 Varicella / Chicken Pox
5.8.1 Doses Administered (Volume) 
5.8.2 Number of Children Being Vaccinated (Volume) 
5.8.3 Market Size and Forecast (Value) 
5.9 Rotavirus
5.9.1 Doses Administered (Volume) 
5.9.2 Number of Children Being Vaccinated (Volume) 
5.9.3 Market Size and Forecast (Value) 
5.10 Influenza Pediatric
5.10.1 Doses Administered (Volume) 
5.10.2 Number of Children Being Vaccinated (Volume) 
5.10.3 Market Size and Forecast (Value) 

6. Preventable Diseases and their Vaccines Available in the Market

7. United States Pediatric Vaccines Pricing Trends and Analysis

8. Regulatory Framework of the United States Pediatric Vaccines Market

9. Key Companies Analysis
9.1 Sanofi Pasteur
9.1.1 Business Overview
9.1.2 Pediatric Vaccines Portfolio
9.1.3 Recent Development
9.2 GlaxoSmithKline (GSK) 
9.2.1 Business Overview
9.2.2 Pediatric Vaccines Portfolio
9.2.3 Recent Development
9.3 Merck
9.3.1 Business Overview
9.3.2 Pediatric Vaccines Portfolio
9.3.3 Recent Development
9.4 Pfizer
9.4.1 Business Overview
9.4.2 Pediatric Vaccines Portfolio
9.4.3 Recent Development
9.5 Grifols
9.5.1 Business Overview
9.5.2 Pediatric Vaccines Portfolio
9.5.3 Recent Development

List of Tables:

Table 3–1: United States Pediatric Vaccines Market Share (Percent), 2015 – 2019
Table 3–2: United States Pediatric Vaccines Market Share Forecast (Percent), 2020 – 2027
Table 6–1: Preventable Diseases and their Vaccines Available in the Market
Table 7–1: United States Pediatric Vaccines Price, 2020 – 2021
Table 8–1: United States Simplified Regulatory Pathway from Preclinical to the Marketing Authorization


List of Figures:

Figure 2–1: United States Pediatric Vaccines Market (Million US$), 2015 – 2019
Figure 2–2: United States Pediatric Vaccines Market Forecast (Million US$), 2020 – 2027
Figure 5–1: Polio Vaccines Doses Administered (in Million), 2015 – 2019
Figure 5–2: Polio Vaccines Doses Administered Forecast (in Million), 2020 – 2027
Figure 5–3: Number of Children Being Vaccinated with Polio Vaccines (in Million), 2015 – 2019
Figure 5–4: Number of Children Being Vaccinated with Polio Vaccines Forecast (in Million), 2020 –2027
Figure 5–5: Polio Vaccines Market Value (in Million US$), 2015 – 2019
Figure 5–6: Polio Vaccines Market Value Forecast (in Million US$), 2020 – 2027
Figure 5–7: Hepatitis B Vaccines Doses Administered (in Million), 2015 – 2019
Figure 5–8: Hepatitis B Vaccines Doses Administered Forecast (in Million), 2020 – 2027
Figure 5–9: Number of Children Being Vaccinated with Hepatitis B Vaccines (in Million), 2015 – 2019
Figure 5–10: Number of Children Being Vaccinated with Hepatitis B Vaccines Forecast (in Million), 2020 –2027
Figure 5–11: Hepatitis B Vaccines Market Value (in Million US$), 2015 – 2019
Figure 5–12: Hepatitis B Vaccines Market Value Forecast (in Million US$), 2020 – 2027
Figure 5–13: Hepatitis A Vaccines Doses Administered (in Million), 2015 – 2019
Figure 5–14: Hepatitis A Vaccines Doses Administered Forecast (in Million), 2020 – 2027
Figure 5–15: Number of Children Being Vaccinated with Hepatitis A Vaccines (in Million), 2015 – 2019
Figure 5–16: Number of Children Being Vaccinated with Hepatitis A Vaccines Forecast (in Million), 2020 –2027
Figure 5–17: Hepatitis A Vaccines Market Value (in Million US$), 2015 – 2019
Figure 5–18: Hepatitis A Vaccines Market Value Forecast (in Million US$), 2020 – 2027
Figure 5–19: DTaP Vaccines Doses Administered (in Million), 2015 – 2019
Figure 5–20: DTap Vaccines Doses Administered Forecast (in Million), 2020 – 2027
Figure 5–21: Number of Children Being Vaccinated with DTaP Vaccines (in Million), 2015 – 2019
Figure 5–22: Number of Children Being Vaccinated with DTaP Vaccines Forecast (in Million), 2020 –2027
Figure 5–23: DTaP Vaccines Market Value (in Million US$), 2015 – 2019
Figure 5–24: DTaP Vaccines Market Value Forecast (in Million US$), 2020 – 2027
Figure 5–25: HIB Vaccines Doses Administered (in Million), 2015 – 2019
Figure 5–26: HIB Vaccines Doses Administered Forecast (in Million), 2020 – 2027
Figure 5–27: Number of Children Being Vaccinated with HIB Vaccines (in Million), 2015 – 2019
Figure 5–28: Number of Children Being Vaccinated with HIB Vaccines Forecast (in Million), 2020 –2027
Figure 5–29: HIB Vaccines Market Value (in Million US$), 2015 – 2019
Figure 5–30: HIB Vaccines Market Value Forecast (in Million US$), 2020 – 2027
Figure 5–31: Pneumococcal Vaccines Doses Administered (in Million), 2015 – 2019
Figure 5–32: Pneumococcal Vaccines Doses Administered Forecast (in Million), 2020 – 2027
Figure 5–33: Number of Children Being Vaccinated with Pneumococcal Vaccines (in Million), 2015 – 2019
Figure 5–34: Number of Children Being Vaccinated with Pneumococcal Vaccines Forecast (in Million), 2020 –2027
Figure 5–35: Pneumococcal Vaccines Market Value (in Million US$), 2015 – 2019
Figure 5–36: Pneumococcal Vaccines Market Value Forecast (in Million US$), 2020 – 2027
Figure 5–37: MMR Vaccines Doses Administered (in Million), 2015 – 2019
Figure 5–38: MMR Vaccines Doses Administered Forecast (in Million), 2020 – 2027
Figure 5–39: Number of Children Being Vaccinated with MMR Vaccines (in Million), 2015 – 2019
Figure 5–40: Number of Children Being Vaccinated with MMR Vaccines Forecast (in Million), 2020 –2027
Figure 5–41: MMR Vaccines Market Value (in Million US$), 2015 – 2019
Figure 5–42: MMR Vaccines Market Value Forecast (in Million US$), 2020 – 2027
Figure 5–43: Varicella Vaccines Doses Administered (in Million), 2015 – 2019
Figure 5–44: Varicella Vaccines Doses Administered Forecast (in Million), 2020 – 2027
Figure 5–45: Number of Children Being Vaccinated with Varicella Vaccines (in Million), 2015 – 2019
Figure 5–46: Number of Children Being Vaccinated with Varicella Vaccines Forecast (in Million), 2020 –2027
Figure 5–47: Varicella Vaccines Market Value (in Million US$), 2015 – 2019
Figure 5–48: Varicella Vaccines Market Value Forecast (in Million US$), 2020 – 2027
Figure 5–49: Rotavirus Vaccines Doses Administered (in Million), 2015 – 2019
Figure 5–50: Rotavirus Vaccines Doses Administered Forecast (in Million), 2020 – 2027
Figure 5–51: Number of Children Being Vaccinated with Rotavirus Vaccines (in Million), 2015 – 2019
Figure 5–52: Number of Children Being Vaccinated with Rotavirus Vaccines Forecast (in Million), 2020 –2027
Figure 5–53: Rotavirus Vaccines Market Value (in Million US$), 2015 – 2019
Figure 5–54: Rotavirus Vaccines Market Value Forecast (in Million US$), 2020 – 2027
Figure 5–55: Influenza Pediatric Vaccines Doses Administered (in Million), 2015 – 2019
Figure 5–56: Influenza Pediatric Vaccines Doses Administered Forecast (in Million), 2020 – 2027
Figure 5–57: Number of Children Being Vaccinated with Influenza Pediatric Vaccines (in Million), 2015 – 2019
Figure 5–58: Number of Children Being Vaccinated with Influenza Pediatric Vaccines Forecast (in Million), 2020 –2027
Figure 5–59: Influenza Pediatric Vaccines Market Value (in Million US$), 2015 – 2019
Figure 5–60: Influenza Pediatric Vaccines Market Value Forecast (in Million US$), 2020 – 2027
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
United States Pediatric Vaccines Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
United States Pediatric Vaccines Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
United States Pediatric Vaccines Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports